Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleCost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States.AuthorsZhang, Shujing; Bensimon, Arielle G.; Xu, Ruifeng; Jiang, Ruixuan; Greatsinger, Alexandra; Zhang, Adina; Fukunaga-Kalabis, Mizuho; Krepler, ClemensPublicationAdvances in Therapy, 2023, Vol 40, Issue 7, p3038ISSN0741-238XPublication typeArticleDOI10.1007/s12325-023-02525-x